Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome

被引：3
|
作者：
Moin, Abu Saleh Md [1 ]
Nandakumar, Manjula [1 ]
Sathyapalan, Thozhukat [2 ]
Atkin, Stephen L. [3 ]
Butler, Alexandra E. [1 ]
机构：
[1] Hamad Bin Khalifa Univ HBKU, Qatar Biomed Res Inst QBRI, Qatar Fdn, Diabet Res Ctr DRC, POB 34110, Doha, Qatar
[2] Hull York Med Sch, Acad Endocrinol Diabet & Metab, Kingston Upon Hull, N Humberside, England
[3] Royal Coll Surg Ireland Bahrain, Adliya, Bahrain
来源：
JOURNAL OF TRANSLATIONAL MEDICINE | 2021年 / 19卷 / 01期
关键词：
Biomarkers; Polycystic ovary syndrome; COVID-19; SARS-CoV-2; Platelet degranulation; Coagulation factors;
D O I：
10.1186/s12967-021-02723-7
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Preinfection laboratory parameters may predict COVID-19 severity in tumor patients
    Kiani, Alexander
    Roesch, Romina
    Wendtner, Clemens M.
    Kullmann, Frank
    Kubin, Thomas
    Suedhoff, Thomas
    Augustin, Marinela
    Schaich, Markus
    Muller-Naendrup, Clemens
    Illerhaus, Gerald
    Hartmann, Frank
    Hebart, Holger
    Seggewiss-Bernhardt, Ruth
    Bentz, Martin
    Spaeth-Schwalbe, Ernst
    Reimer, Peter
    Kaiser, Ulrich
    Kapp, Markus
    Graeven, Ullrich
    Chemnitz, Jens-Marcus
    Baesecke, Joerg
    Lambertz, Helmut
    Naumann, Ralph
    CANCER MEDICINE, 2021, 10 (13): : 4424 - 4436
  • [22] Does vitamin D supplementation for COVID-19 increase the chances of fertility in women with polycystic ovary syndrome?
    Heidarzadeh, Hamid
    Bahrami-Vazir, Ellahe
    Mohammadi, Azam
    Mohammadnejad, Sara
    ANAESTHESIA PAIN & INTENSIVE CARE, 2022, 26 (04) : 574 - 575
  • [23] Laboratory biomarkers associated with COVID-19 severity and management
    Keddie, S.
    Ziff, O.
    Chou, M. K. L.
    Taylor, R. L.
    Heslegrave, A.
    Garr, E.
    Lakdawala, N.
    Church, A.
    Ludwig, D.
    Manson, J.
    Scully, M.
    Nastouli, E.
    Chapman, Md
    Hart, M.
    Lunn, Mp
    CLINICAL IMMUNOLOGY, 2020, 221
  • [24] Cardiovascular biomarkers in patients with COVID-19
    Mueller, Christian
    Giannitsis, Evangelos
    Jaffe, Allan S.
    Huber, Kurt
    Mair, Johannes
    Cullen, Louise
    Hammarsten, Ola
    Mills, Nicholas L.
    Moeckel, Martin
    Krychtiuk, Konstantin
    Thygesen, Kristian
    Lindahl, Bertil
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2021, 10 (03) : 310 - 319
  • [25] Metabolomic Biomarkers in Polycystic Ovary Syndrome: A Review of the Evidence
    Alesi, Simon
    Ghelani, Drishti
    Mousa, Aya
    SEMINARS IN REPRODUCTIVE MEDICINE, 2021, 39 (03/04) : 102 - 110
  • [26] The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness
    Keikha, R.
    Hashemi-Shahri, S. M.
    Jebali, A.
    NEUROLOGIA, 2023, 38 (06): : e41 - e51
  • [27] The causal association between polycystic ovary syndrome and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization study using genetic data
    Si, Yu
    Fei, Yuye
    Ma, Hua
    Xu, Yating
    Ning, Li
    Li, Xiu
    Ren, Qingling
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [28] Impact of COVID-19 restriction on weight, physical activity, diet and psychological distress on people with polycystic ovary syndrome
    McGowan, M.
    Lim, S.
    O'Reilly, S. L.
    Harrison, C. L.
    Enticott, J.
    Teede, H.
    Cowan, S.
    Moran, L. J.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2024, 83 (OCE1)
  • [29] Iron Dysregulation: Unveiling Predictive Biomarkers for Severity in COVID-19 Patients
    Shaghaghi, Zahra
    Hashemi, Seyyed Hamid
    Alvandi, Maryam
    Marzhoseyni, Zeynab
    Ghasemi-Basir, Hamidreza
    Mohamadi, Tayeb
    Farzipour, Soghra
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2024,
  • [30] Biomarkers of Oxidative Stress in COVID-19 Patients
    Pavlova, Elitsa
    Atanasov, Petar
    Ivanov, Ivaylo
    Dyankov, Georgi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (08)
12345